Cargando…

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

BACKGROUND: Preliminary data suggest that psilocybin-assisted treatment produces substantial and rapid antidepressant effects in patients with major depressive disorder (MDD), but little is known about long-term outcomes. AIMS: This study sought to examine the efficacy and safety of psilocybin throu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gukasyan, Natalie, Davis, Alan K, Barrett, Frederick S, Cosimano, Mary P, Sepeda, Nathan D, Johnson, Matthew W, Griffiths, Roland R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864328/ https://www.ncbi.nlm.nih.gov/pubmed/35166158 http://dx.doi.org/10.1177/02698811211073759

Ejemplares similares

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
por: Davis, Alan K., et al.
Publicado: (2020)

Emotions and brain function are altered up to one month after a single high dose of psilocybin
por: Barrett, Frederick S., et al.
Publicado: (2020)

Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD
por: Davis, Alan K, et al.
Publicado: (2021)

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
por: Doss, Manoj K., et al.
Publicado: (2021)

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
por: Griffiths, Roland R, et al.
Publicado: (2017)

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
por: Griffiths, Roland R, et al.
Publicado: (2016)

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
por: Garcia-Romeu, Albert, et al.
Publicado: (2021)

Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
por: Nayak, Sandeep M., et al.
Publicado: (2023)

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
por: Carhart-Harris, R. L., et al.
Publicado: (2017)

Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT
por: Griffiths, Roland R., et al.
Publicado: (2019)

Psilocybin-Assisted Compassion Focused Therapy for Depression
por: Pots, Wendy, et al.
Publicado: (2022)

Association of Psilocybin Use in Adolescents with Major Depressive Episode
por: Shah, K., et al.
Publicado: (2022)

Effects of psilocybin-assisted therapy on treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study
por: Barsuglia, Joseph, et al.
Publicado: (2018)

Psilocybin-assisted group therapy: A new hope for demoralization
por: Hendricks, Peter S
Publicado: (2020)

Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review
por: Ziff, Shawn, et al.
Publicado: (2022)

Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder
por: Brett, Jonathan, et al.
Publicado: (2023)

Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial
por: Rucker, James, et al.
Publicado: (2021)

The Therapeutic Potential of Psilocybin
por: Lowe, Henry, et al.
Publicado: (2021)

Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities
por: Yaden, David B, et al.
Publicado: (2021)

Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy
por: Malone, Tara C., et al.
Publicado: (2018)

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
por: Murphy, Roberta, et al.
Publicado: (2022)

Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?
por: Gibbons, William J., et al.
Publicado: (2021)

Outcome after major trauma: 12-month follow-up
por: Anthi, A, et al.
Publicado: (2000)

Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD
por: Davis, Alan K, et al.
Publicado: (2023)

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial
por: von Rotz, Robin, et al.
Publicado: (2022)

Why didn’t the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?
por: Rossell, Susan L, et al.
Publicado: (2023)

Psilocybin: the magic medicine for depression?
por: Corrigan, Amber Elyse, et al.
Publicado: (2021)

Psilocybin: From Serendipity to Credibility?
por: Rucker, James J., et al.
Publicado: (2021)

Electrical spiking of psilocybin fungi
por: Gandia, Antoni, et al.
Publicado: (2022)

Psilocybin in Palliative Care: An Update
por: Whinkin, Emily, et al.
Publicado: (2023)

Psilocybin desynchronizes brain networks
por: Siegel, Joshua S, et al.
Publicado: (2023)

Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives
por: Messell, Catharina, et al.
Publicado: (2022)

A case-study evaluation of the “Copenhagen Music Program” for psilocybin-assisted therapy
por: Ratkovic, Gina, et al.
Publicado: (2023)

Predictors of Medical Students’ Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice
por: Wang, Karina, et al.
Publicado: (2023)

Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
por: von Rotz, Robin, et al.
Publicado: (2023)

Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
por: Heuschkel, Kristin, et al.
Publicado: (2020)

Prediction of Psilocybin Response in Healthy Volunteers
por: Studerus, Erich, et al.
Publicado: (2012)

Effects of psilocybin therapy on personality structure
por: Erritzoe, D., et al.
Publicado: (2018)

Rediscovering Psilocybin as an Antidepressive Treatment Strategy
por: Zeiss, Rene, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mpdq9uiv1tcq95abivqa4bhk80